Spots Global Cancer Trial Database for Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Official Title: Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Study ID: NCT00696488
Conditions
Interventions
Study Description
Brief Summary: The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.
Detailed Description: The purpose of this research study is to measure adherence to the study drug for the treatment of actinic keratoses. The study drug is 5-Fluorouracil (Carac®); it will be used in this study to treat actinic keratoses on the face and anterior scalp. This proposed study will evaluate adherence to topical Carac® in 20 adults age 50 or greater with actinic keratoses from a clinic population. Adherence data will be collected by the MEMS cap (Medication Event Monitoring System
Keywords
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Wake Forest University Health Sciences Dermatology, Winston-Salem, North Carolina, United States
Contact Details
Name: Steve Feldman, MD, PhD
Affiliation: Wake Forest University Health Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
